Growth Metrics

Cellectis (CLLS) EBT: 2013-2022

Historic EBT for Cellectis (CLLS) over the last 10 years, with Dec 2022 value amounting to -$80.8 million.

  • Cellectis' EBT rose 39.55% to -$14.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$40.4 million, marking a year-over-year increase of 24.23%. This contributed to the annual value of -$80.8 million for FY2022, which is 141.85% down from last year.
  • Cellectis' EBT amounted to -$80.8 million in FY2022, which was down 141.85% from -$33.4 million recorded in FY2021.
  • Over the past 5 years, Cellectis' EBT peaked at -$33.4 million during FY2021, and registered a low of -$123.6 million during FY2019.
  • Moreover, its 3-year median value for EBT was -$37.5 million (2020), whereas its average is -$50.6 million.
  • In the last 5 years, Cellectis' EBT soared by 69.68% in 2020 and then tumbled by 141.85% in 2022.
  • Over the past 5 years, Cellectis' EBT (Yearly) stood at -$88.3 million in 2018, then crashed by 39.87% to -$123.6 million in 2019, then spiked by 69.68% to -$37.5 million in 2020, then climbed by 10.84% to -$33.4 million in 2021, then crashed by 141.85% to -$80.8 million in 2022.